byiShook Opinion
Dec 10, 2024 - 10:25
UniQure stock nearly doubled Tuesday after the company reached a testing agreement with the FDA for its Huntington's disease treatment. The post UniQure Stock Nearly Doubles After Striking A Deal With The FDA For Huntington's Drug appeared first on Investor's Business Daily.
UniQure stock nearly doubled Tuesday after the company reached a testing agreement with the FDA for its Huntington's disease treatment.
The post UniQure Stock Nearly Doubles After Striking A Deal With The FDA For Huntington's Drug appeared first on Investor's Business Daily.